For instance, a dose of 7 mg oral semaglutide in the PIONEER 8 trial caused a lower percentage of patients discontinuing treatment compared to 14 mg oral semaglutide (7 mg: 9% and 14 mg: 13%, respectively) (Zinman et al., 2019a)
See Whether You Qualify for GLP-1 Treatment Complete a 5-minute intake so a licensed provider can review your health history, weight goals, and whether GLP-1 treatment may be appropriate
Opt for Low-Glycemic Sweeteners : Natural options like allulose (e.g., RxSugar) satisfy sweet cravings without raising blood sugar
Routine lab testing can be a barrier to care for some patients who cannot take off work or arrange transportation to visit an in-person clinic or phlebotomist
most commonly, patients reported taking metformin (91%) and insulin glargine or an insulin glargine biosimilar (50%)
10.1183/09031936.00003309 73 GBD Chronic Respiratory Disease Collaborators (2020)